STOCK TITAN
  1. Home
  2. Sec-filings
  3. KRMD
  4. [Form 4/A] KORU Medical Systems, Inc. Amended Insider Trading Activity

Major KRMD holder Horton Capital fund granted 3,472 KORU Medical shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

Manko Joseph M. Jr. reported acquisition or exercise transactions in this Form 4 filing.

KORU Medical Systems insider group reported an additional share award. On March 31, 2026, an entity identified as Horton Capital Partners Fund, L.P., which is associated with a ten percent owner, received a grant of 3,472 shares of Common Stock at $0.00 per share, reported as indirect ownership.

The filing also shows that, after this award, the indirectly held position reported for this fund stands at 5,065,970 shares of KORU Medical Systems Common Stock, while a separate direct holding line reflects 782,547 shares. This amendment mainly updates the recorded ownership levels rather than reflecting open‑market trading activity.

Positive

  • None.

Negative

  • None.
Insider Manko Joseph M. Jr., Horton Capital Management, LLC, Horton Capital Partners, LLC, Horton Capital Partners Fund, L.P.
Role Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner
Type Security Shares Price Value
Grant/Award Common Stock 3,472 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 5,065,970 shares (Indirect, By Horton Capital Partners Fund, LP); Common Stock — 782,547 shares (Direct)
Footnotes (1)
  1. See Exhibit 99.1 to this Form 4 for explanation of note (1). See Exhibit 99.1 to this Form 4 for explanation of note (2). See Exhibit 99.1 to this Form 4 for explanation of note (3).
Granted shares 3,472 shares Common Stock grant on March 31, 2026
Grant price $0.00 per share Price per share for 3,472-share award
Indirect holdings after grant 5,065,970 shares Total Common Stock indirectly held by Horton Capital Partners Fund, L.P.
Direct holdings line 782,547 shares Directly held Common Stock position reported in the filing
ten percent owner financial
"reporting persons include multiple entities each marked as a ten percent owner"
indirect ownership financial
"the 3,472-share grant is reported with ownership type marked as indirect"
grant/award acquisition financial
"transaction_action is classified as a grant/award acquisition for the new shares"
Common Stock financial
"each transaction involves KORU Medical Systems, Inc. Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
04/01/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026A3,472A$0(1)5,065,970IBy Horton Capital Partners Fund, LP(2)
Common Stock782,547(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Management, LLC
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners, LLC
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners Fund, L.P.
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. See Exhibit 99.1 to this Form 4 for explanation of note (1).
2. See Exhibit 99.1 to this Form 4 for explanation of note (2).
3. See Exhibit 99.1 to this Form 4 for explanation of note (3).
Remarks:
This Form amends reporting persons' original Form 4 filed on April 1, 2026. The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.
/s/ Joseph M. Manko, Jr.04/06/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Management, LLC04/06/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC04/06/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP04/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did KRMD report in this Form 4/A amendment?

KORU Medical Systems reported an additional share award to an entity associated with a ten percent owner. Horton Capital Partners Fund, L.P. received a grant of 3,472 Common Stock shares at $0.00 per share, increasing its indirectly reported holdings without any open‑market buying or selling.

Who acquired shares of KORU Medical Systems (KRMD) in this filing?

Horton Capital Partners Fund, L.P. is shown as the acquiring entity. The shares are reported as indirectly owned, tied to reporting persons including Joseph M. Manko Jr. as a ten percent owner, reflecting an internal grant or award rather than a public market purchase.

How many KRMD shares were granted in the reported transaction?

The filing records a grant of 3,472 Common Stock shares on March 31, 2026. These shares were acquired at a stated price of $0.00 per share, indicating a grant or award classification instead of an open‑market transaction, and are held indirectly through Horton Capital Partners Fund, L.P.

What are the indirect KRMD holdings after this insider share award?

After the reported grant, indirect holdings total 5,065,970 shares of KORU Medical Systems Common Stock for Horton Capital Partners Fund, L.P. This figure reflects the position following the 3,472‑share award and provides context for the scale of the entity’s reported ownership stake.

Does the KRMD Form 4/A show any insider sales or open‑market buys?

The amendment does not report any open‑market sales or purchases. It records a grant or award acquisition of 3,472 shares at $0.00 per share and a separate holding line, emphasizing updated ownership information rather than trading activity in the public market.

What direct KRMD holdings are shown alongside the indirect position?

The filing lists a direct holding of 782,547 Common Stock shares in addition to the indirect stake. This separate line indicates shares held directly, complementing the 5,065,970 shares indirectly reported through Horton Capital Partners Fund, L.P. after the grant transaction.